Evaluation of the Major Histocompatibility Complex (MHC) Class II As a Candidate for Sudden Acquired Retinal Degeneration Syndrome (SARDS) in Dachshunds

Overview

Journal Vet Ophthalmol

Specialties Ophthalmology
Veterinary Medicine

Date 2019 Feb 22

PMID 30791205

Citations 6

Authors

Stephanie J Stromberg

Sara M Thomasy

Ariana D Marangakis

Soohyun Kim

Ann E Cooper

Emily A Brown

David J Maggs

Danika L Bannasch

Affiliations

Soon will be listed here.

Abstract

Objective: Sudden acquired retinal degeneration syndrome (SARDS) is one of the leading causes of acute blindness in dogs, with an unknown etiology and no effective treatment. Certain breeds such as Dachshunds are overrepresented among SARDS patients, and therefore, the syndrome is suspected to have a genetic component. The objective of this study was to determine if a genetic locus associated with SARDS in Dachshunds could be identified using a genome-wide association study (GWAS).

Procedures: Genome-wide association mapping was performed in 15 SARDS-affected and 16 unaffected Dachshunds. Genotyping of three classical DLA class II genes (DLA-DRB1, DLA-DQA1, and DLA-DQB1) was performed in 34 SARDS-affected and 66 unaffected Dachshunds to evaluate for an association in this region.

Results: Although no single nucleotide polymorphisms (SNPs) were of genome-wide statistical significance (P < 0.05), 5 of the top 9 SNPs were in the major histocompatibility complex (MHC). Using DLA typing, the allele DLA-DRB1*09401 was identified as a risk factor for the development of SARDS (P = 0.0032, OR = 4.0). The alleles DLA-DQB1*00101 (P = 0.0050, OR = 0.31), DLA-DQA1*00901 (P = 0.0087, OR = 0.33), and a previously identified DLA-DRB1allele described as "DRB1-T" (P = 0.0284, OR = 0.37) were identified as protective factors.

Conclusions: Although far from definitive, association of SARDS with alleles of immunologic importance further supports the hypothesis that autoimmunity may play a role in the pathogenesis of SARDS.

Citing Articles

Dog leukocyte antigen genotyping across class I and class II genes in beagle dogs as laboratory animals.

Konno H, Miyamae J, Kataoka H, Akai M, Miida H, Tsuchiya Y Immunogenetics. 2024; 76(4):261-270.

PMID: 38922357 DOI: 10.1007/s00251-024-01344-w.

Large-Scale Polymorphism Analysis of Dog Leukocyte Antigen Class I and Class II Genes (, and ) and Comparison of the Haplotype Diversity between Breeds in Japan.

Miyamae J, Okano M, Katakura F, Kulski J, Moritomo T, Shiina T Cells. 2023; 12(5).

PMID: 36899945 PMC: 10001263. DOI: 10.3390/cells12050809.

Dog leukocyte antigen class II alleles and haplotypes associated with meningoencephalomyelitis of unknown origin in Chihuahuas.

Oshima A, Ito D, Katakura F, Miyamae J, Okano M, Nakazawa M J Vet Med Sci. 2022; 85(1):62-70.

PMID: 36418080 PMC: 9887217. DOI: 10.1292/jvms.22-0116.

Canine sudden acquired retinal degeneration syndrome: Owner perceptions on the time to vision loss, treatment outcomes, and prognosis for life.

Washington D, Li Z, Fox L, Mowat F Vet Ophthalmol. 2020; 24(2):156-168.

PMID: 33377263 PMC: 7979495. DOI: 10.1111/vop.12855.

Presumed cancer-associated retinopathy (CAR) mimicking Sudden Acquired Retinal Degeneration Syndrome (SARDS) in canines.

Grozdanic S, Lazic T, Kecova H, Mohan K, Adamus G, Kuehn M Vet Ophthalmol. 2020; 24(2):125-155.

PMID: 33369040 PMC: 8048582. DOI: 10.1111/vop.12853.

References

Komaromy A, Abrams K, Heckenlively J, Lundy S, Maggs D, Leeth C . Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapy. Vet Ophthalmol. 2015; 19(4):319-31. DOI: 10.1111/vop.12291. View

Carter R, Oliver J, Stepien R, Bentley E . Elevations in sex hormones in dogs with sudden acquired retinal degeneration syndrome (SARDS). J Am Anim Hosp Assoc. 2009; 45(5):207-14. DOI: 10.5326/0450207. View

Dyggve H, Kennedy L, Meri S, Spillmann T, Lohi H, Speeti M . Association of Doberman hepatitis to canine major histocompatibility complex II. Tissue Antigens. 2010; 77(1):30-5. DOI: 10.1111/j.1399-0039.2010.01575.x. View

Grange L, Dalal M, Nussenblatt R, Sen H . Autoimmune retinopathy. Am J Ophthalmol. 2013; 157(2):266-272.e1. PMC: 3946999. DOI: 10.1016/j.ajo.2013.09.019. View

Heller A, Van Der Woerdt A, Gaarder J, Sapienza J, Hernandez-Merino E, Abrams K . Sudden acquired retinal degeneration in dogs: breed distribution of 495 canines. Vet Ophthalmol. 2016; 20(2):103-106. DOI: 10.1111/vop.12370. View

Safra N, Pedersen N, Wolf Z, Johnson E, Liu H, Hughes A . Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations. Vet J. 2011; 189(2):220-6. PMC: 3152640. DOI: 10.1016/j.tvjl.2011.06.023. View

Wilbe M, Jokinen P, Hermanrud C, Kennedy L, Strandberg E, Hansson-Hamlin H . MHC class II polymorphism is associated with a canine SLE-related disease complex. Immunogenetics. 2009; 61(8):557-64. DOI: 10.1007/s00251-009-0387-6. View

Grozdanic S, Harper M, Kecova H . Antibody-mediated retinopathies in canine patients: mechanism, diagnosis, and treatment modalities. Vet Clin North Am Small Anim Pract. 2008; 38(2):361-87, vii. DOI: 10.1016/j.cvsm.2007.12.003. View

Auten C, Thomasy S, Kass P, Good K, Hollingsworth S, Maggs D . Cofactors associated with Sudden Acquired Retinal Degeneration Syndrome: 151 dogs within a reference population. Vet Ophthalmol. 2017; 21(3):264-272. DOI: 10.1111/vop.12504. View

10.

Karlsson E, Baranowska I, Wade C, Salmon Hillbertz N, Zody M, Anderson N . Efficient mapping of mendelian traits in dogs through genome-wide association. Nat Genet. 2007; 39(11):1321-8. DOI: 10.1038/ng.2007.10. View

11.

Kennedy A, Ozbek U, Dorak M . What has GWAS done for HLA and disease associations?. Int J Immunogenet. 2017; 44(5):195-211. DOI: 10.1111/iji.12332. View

12.

Raymond C, Kas A, Paddock M, Qiu R, Zhou Y, Subramanian S . Ancient haplotypes of the HLA Class II region. Genome Res. 2005; 15(9):1250-7. PMC: 1199539. DOI: 10.1101/gr.3554305. View

13.

Massey J, Boag A, Short A, Scholey R, Henthorn P, Littman M . MHC class II association study in eight breeds of dog with hypoadrenocorticism. Immunogenetics. 2013; 65(4):291-7. DOI: 10.1007/s00251-013-0680-2. View

14.

Ettinger R, Papadopoulos G, Moustakas A, Nepom G, Kwok W . Allelic variation in key peptide-binding pockets discriminates between closely related diabetes-protective and diabetes-susceptible HLA-DQB1*06 alleles. J Immunol. 2006; 176(3):1988-98. DOI: 10.4049/jimmunol.176.3.1988. View

15.

Jawaheer D, Li W, Graham R, Chen W, Damle A, Xiao X . Dissecting the genetic complexity of the association between human leukocyte antigens and rheumatoid arthritis. Am J Hum Genet. 2002; 71(3):585-94. PMC: 449696. DOI: 10.1086/342407. View

16.

Wolf Z, Vernau K, Safra N, Shelton G, King J, Owen J . Association of early onset myasthenia gravis in Newfoundland dogs with the canine major histocompatibility complex class I. Neuromuscul Disord. 2017; 27(5):409-416. DOI: 10.1016/j.nmd.2017.01.020. View

17.

Kennedy L, Barnes A, Ollier W, Day M . Association of a common dog leucocyte antigen class II haplotype with canine primary immune-mediated haemolytic anaemia. Tissue Antigens. 2006; 68(6):502-8. DOI: 10.1111/j.1399-0039.2006.00715.x. View

18.

Kennedy L, Barnes A, Short A, Brown J, Lester S, Seddon J . Canine DLA diversity: 1. New alleles and haplotypes. Tissue Antigens. 2007; 69 Suppl 1:272-88. DOI: 10.1111/j.1399-0039.2006.00779.x. View

19.

Perneger T . What's wrong with Bonferroni adjustments. BMJ. 1998; 316(7139):1236-8. PMC: 1112991. DOI: 10.1136/bmj.316.7139.1236. View

20.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira M, Bender D . PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007; 81(3):559-75. PMC: 1950838. DOI: 10.1086/519795. View